Biologics vs. JAK Inhibitors for Atopic Dermatitis: Which One Wins for Your Patient? A 2026 Practical Guide 3/08/2026 Atopic Dermatitis Biologics Dupilumab JAK inhibitors +
Tezepelumab in Real-World Danish Severe Asthma Study: Benefits Even After Biologic Switches 3/04/2026 Asthma Biologics Tezepelumab +
Tezepelumab vs. Dupilumab in Severe Asthma: Head-to-Head Real-World Data Shows No Clear Winner 3/03/2026 Asthma Biologics Dupilumab Tezepelumab +